WAYWaystar Holding Corp.

$24.22

$17.3152 weeks$40.89

Price

$24.22-33%1Y

1M+3.6%1Y-33%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Below average

3/10

Value32

Quality58

Momentum23

Growth67

Strongest Growth, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Healthcare is one of the largest and most complex vertical end-markets within the U.S. economy, accounting for 18.0% of the U.S. gross domestic product as of 2024. According to the Council for Affordable Quality Healthcare (CAQH), total U.S. healthcare spending was $4.9 trillion in 2024. National health expenditures are expected to grow 5.8% annually reaching 20.3% of GDP in 2033. According to the CAQH, the U.S. spends $440 billion on healthcare administrative costs per year.

In the company’s own words · 10-K filed Feb 17, 2026 · SEC EDGAR

P/E (TTM)34.6

Market Cap$3.64B

1Y Return-33%

5Y Return-

Business segments

Q2 2026 · $87.9M

The company’s own SEC segment disclosure.

Volume Based$84.1M96%
Subscription And Circulation$3.5M4%
Implementation Services And Other$296.0K0%

Waystar Holding Corp. (WAY) reported revenue of $320M in Q2 2026 (quarter ended Jun 30, 2026), up 18% from the same quarter a year earlier. That came with a gross margin of 69% and net income of $41M (13% of revenue). For the full year FY2025, revenue was $1.10B (+17% year on year) and net income $112M. Its largest product in Q2 2026 was Volume Based at $84M, 96% of the disclosed total, well ahead of Subscription And Circulation at 4.0%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Health Information Services

Ranks #7 of 13 by Smart Score

Privia Health Group, Inc.